Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sitagliptin, Lansoprazole, and Diamyd in New Onset Type 1 Diabetes
NCT00837759Phase 2Terminated
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases
- Start
- Feb 2009
- Primary completion
- Mar 2011
- Modality
- Recombinant Proteins and Enzymes, Subcutaneous Immunotherapy, Sublingual Immunotherapy
- Countries
- 1
01
Overview
A Phase 2 trial of sitagliptin, lansoprazole, Diamyd in type 1 diabetes mellitus (T1D), sponsored by National Institute of Diabetes and Digestive and Kidney Diseases. Started Feb 2009; status: terminated.
02
Drugs
sitagliptinlansoprazoleDiamyd
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT00837759.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00837759.